Authors:
Mira, Y
Todoli, J
Alonso, R
Mico, ML
Vaya, A
Ferrando, F
Estelles, A
Villa, P
Aznar, J
Citation: Y. Mira et al., Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases, CL APPL T-H, 7(3), 2001, pp. 234-237
Authors:
Vaya, A
Todoli, J
Ricart, J
Estelles, A
Mira, Y
Villa, P
Calabuig, JR
Aznar, J
Citation: A. Vaya et al., Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation, CL APPL T-H, 7(1), 2001, pp. 72-74
Authors:
Vila, V
Martinez-Sales, V
Reganon, E
Peris, E
Perez, F
Ruano, M
Aznar, J
Citation: V. Vila et al., Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes, HAEMATOLOG, 86(7), 2001, pp. 729-734
Authors:
Villa, P
Iborra, J
Serra, J
Gilsanz, A
Casana, P
Aznar, JA
Aznar, J
Citation: P. Villa et al., Evaluation of an automated method for the quantification of von Willebrandfactor antigen. Its application in the study of vascular dysfunction, HAEMATOLOG, 86(11), 2001, pp. 1180-1185
Authors:
Falco, C
Tormo, G
Estelles, A
Espana, F
Tormo, E
Gilabert, J
Velasco, JA
Aznar, J
Citation: C. Falco et al., Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy, HAEMATOLOG, 86(1), 2001, pp. 92-98
Authors:
Estelles, A
Dalmou, J
Falco, C
Berbel, O
Castello, R
Espana, F
Aznar, J
Citation: A. Estelles et al., Plasma PAI-1 levels in obese children - Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype, THROMB HAEM, 86(2), 2001, pp. 647-652
Authors:
Vaya, A
Garcia, M
Mira, Y
Ferrando, F
Villa, P
Estelles, A
Aznar, J
Citation: A. Vaya et al., Homozygous 20210G/A prothrombin gene mutation associated with bilateral iliac vein thrombosis: A case report, THROMB RES, 104(4), 2001, pp. 293-296
Authors:
Aznar, J
Cerrada, E
Hursthouse, MB
Laguna, M
Pozo, C
Romero, MP
Citation: J. Aznar et al., Heteronuclear tin(IV)-silver(I) complexes with phosphinothiolate ligands. X-ray structure of [AgSn(mu-SC6H4PPh2)(2)Me-2(PPh2Me)]CF3SO3 center dot CH2Cl2, J ORGMET CH, 622(1-2), 2001, pp. 274-279
Authors:
Martinez, M
Vaya, A
Lopez-Camacho, C
Coll-Sangrona, E
Mira, Y
Aznar, J
Citation: M. Martinez et al., High and low molecular weight heparins do not modify red blood cell aggregability in vitro, CL HEMORH M, 23(1), 2000, pp. 67-70
Citation: Y. Mira et al., Congenital and acquired thrombotic risk factors in women using oral contraceptives: Clinical aspects, CL APPL T-H, 6(3), 2000, pp. 162-168
Authors:
Mira, Y
del Castillo, GG
Estelles, A
Villa, P
Vaya, A
Ortuno, C
Aznar, J
Citation: Y. Mira et al., Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiency, CL APPL T-H, 6(3), 2000, pp. 179-180
Authors:
Villa, P
Ferrando, F
Serra, J
Faus, H
Mira, Y
Vaya, A
Aznar, J
Citation: P. Villa et al., Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis, HAEMATOLOG, 85(5), 2000, pp. 520-524
Authors:
Vaya, A
Forner, MJ
Estelles, A
Villa, P
Mira, Y
Ferrando, F
Fuster, MJG
Oliver, V
Aznar, J
Citation: A. Vaya et al., Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation, HAEMATOLOG, 85(4), 2000, pp. 425-428
Authors:
Aznar, J
Vaya, A
Estelles, A
Mira, Y
Segui, R
Villa, P
Citation: J. Aznar et al., Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives, HAEMATOLOG, 85(12), 2000, pp. 1271-1276
Authors:
Estelles, A
Villa, P
Mira, Y
Vaya, A
Segui, R
Aznar, J
Citation: A. Estelles et al., Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familialthrombophilia, HAEMATOLOG, 85(1), 2000, pp. 111-112
Authors:
Martinez, M
Espana, F
Royo, M
Vera, CD
Estelles, A
Jimenez-Cruz, JF
Medina, P
Aznar, J
Citation: M. Martinez et al., Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer, EUR UROL, 38(1), 2000, pp. 85-90
Authors:
Aros, F
Boraita, A
Alegria, E
Alonso, AM
Bardaji, A
Lamiel, R
Luengo, E
Rabadan, M
Alijarde, M
Aznar, J
Bano, A
Cabanero, M
Calderon, C
Camprubi, M
Candell, J
Crespo, M
de la Morena, G
Fernandez, A
Ferrero, JA
Gayan, R
Bolao, IG
Hernandez, M
Maceira, A
Marin, E
de Lara, AM
Placer, L
San Roman, JAS
Serratosa, L
Sosa, V
Subirana, MT
Wilke, M
Citation: F. Aros et al., Guidelines of the Spanish Society of Cardiology for clinical practice in exercise testing, REV ESP CAR, 53(8), 2000, pp. 1063-1094
Authors:
Torres, MJ
Criado, A
Palomares, JC
Aznar, J
Citation: Mj. Torres et al., Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis, J CLIN MICR, 38(9), 2000, pp. 3194-3199
Authors:
Santos, MT
Moscardo, A
Valles, J
Martinez, M
Pinon, M
Aznar, J
Broekman, MJ
Marcus, AJ
Citation: Mt. Santos et al., Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets, CIRCULATION, 102(16), 2000, pp. 1924-1930
Authors:
Segui, R
Estelles, A
Mira, Y
Espana, F
Villa, P
Falco, C
Vaya, A
Grancha, S
Ferrando, F
Aznar, J
Citation: R. Segui et al., PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects, BR J HAEM, 111(1), 2000, pp. 122-128